查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1548181

全球止血与组织封闭剂市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Hemostasis and Tissue Sealing Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球止血和组织封闭剂市场需求预计将从 2023 年的 85.2 亿美元达到 2032 年近 193.1 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 9.51%。

止血和组织封闭剂是用于外科手术过程中控制出血和促进组织修復的医疗产品。这些药物包括局部止血剂、密封剂和黏合剂，旨在透过促进凝块形成或密封组织来快速止血。这些试剂通常用于各种外科专业，可以源自生物材料，例如胶原蛋白或纤维蛋白，也可以是合成的。它们的主要功能是透过减少出血相关併发症和促进更快的癒合来提高手术效果。这些产品直接应用于出血部位或组织界面，以实现有效止血并确保组织黏附。

市场动态

心血管、骨科和普通外科等不同医疗领域的外科手术数量不断增加，推动了止血和组织封闭剂市场的发展。微创手术的需求不断增长，需要有效的止血和密封解决方案来控制出血和促进康復，这进一步支持了市场成长。技术进步，例如开发具有更高功效和生物相容性的先进密封剂配方，带来了重大机会。透过创新止血产品减少手术併发症和改善患者治疗效果的关注推动了市场扩张。此外，需要手术干预的慢性病和创伤病例的日益流行也导致了这些药物的使用增加。随着医疗保健基础设施和手术能力的不断扩大，新兴市场也为止血和组织封闭剂提供了成长潜力。然而，高成本和潜在的过敏反应可能会抑制止血剂和组织封闭剂的发展。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球止血和组织密封剂市场的各个细分市场进行了包容性评估。止血和组织密封剂产业的成长和趋势为本研究提供了整体方法。

市场区隔

止血和组织密封剂市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 局部止血剂（主动式、机械式、流动式）
  • 黏合剂和组织密封剂（合成组织密封剂、天然组织密封剂、黏连屏障产品）

按材质

  • 明胶局部止血剂
  • 胶原蛋白局部止血剂
  • 基于 ORC 的局部止血剂
  • 多醣体局部止血剂

按申请

  • 一般外科
  • 神经外科
  • 血管外科
  • 心血管外科
  • 其他的

按最终用途

  • 医院
  • 门诊手术中心
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲止血和组织密封剂市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。止血和组织密封剂市场的主要参与者包括强生公司、CryoLife Inc.、Advance Medical Solution (AMS) Group Plc.、Cohera Medical Inc.、Integra Life Sciences Corporation、辉瑞公司、BD、Baxter、HyperBranch Medical技术、Biomet Inc、B Braun Medical Inc、Smith & Nephew。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：止血与组织封闭剂 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按材料分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球止血与组织封闭剂市场分析：副产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 局部止血剂（主动式、机械式、流动式）
  • 黏合剂和组织密封剂（合成组织密封剂、天然组织密封剂、黏连屏障产品）

第 6 章：全球止血与组织封闭剂市场分析：依材料分类

  • 按材料概述
  • 按材料进行的历史和预测数据分析
  • 明胶局部止血剂
  • 胶原蛋白局部止血剂
  • 基于 ORC 的局部止血剂
  • 多醣体局部止血剂

第 7 章：全球止血与组织封闭剂市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 一般外科
  • 神经外科
  • 血管外科
  • 心血管外科
  • 其他的

第 8 章：全球止血与组织封闭剂市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 医院
  • 门诊手术中心
  • 其他的

第 9 章：全球止血与组织封闭剂市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：止血剂和组织封闭剂公司的竞争格局

  • 止血和组织封闭剂市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Johnson & Johnson
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • CryoLife Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Advance Medical Solution (AMS) Group Plc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cohera Medical Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Integra Life Sciences Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BD
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Baxter
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • HyperBranch Medical Technology
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Biomet Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • B Braun Medical Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Smith & Nephew
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115538

The global demand for Hemostasis and Tissue Sealing Agents Market is presumed to reach the market size of nearly USD 19.31 Billion by 2032 from USD 8.52 Billion in 2023 with a CAGR of 9.51% under the study period 2024-2032.

Hemostasis and tissue sealing agents are medical products utilized to control bleeding and facilitate tissue repair during surgical procedures. These agents, including topical hemostats, sealants, and adhesives, are designed to quickly stop bleeding by promoting clot formation or sealing tissues. Commonly used in various surgical specialties, these agents can be derived from biological materials, such as collagen or fibrin, or be synthetic. Their primary function is to enhance surgical outcomes by reducing bleeding-related complications and promoting faster healing. These products are applied directly to the bleeding site or tissue interface to achieve effective hemostasis and secure tissue adhesion.

MARKET DYNAMICS

The hemostasis and tissue sealing agents market is fuelled by the increasing number of surgical procedures across diverse medical fields, including cardiovascular, orthopedic, and general surgery. The propelling demand for minimally invasive surgeries, which require effective hemostatic and sealing solutions to manage bleeding and enhance recovery, further supports market growth. Technological advancements, such as developing advanced sealant formulations with improved efficacy and biocompatibility, present significant opportunities. The focus on reducing surgical complications and improving patient outcomes through innovative hemostatic products drives market expansion. Additionally, the growing prevalence of chronic conditions and trauma cases that necessitate surgical intervention contributes to the increased use of these agents. With expanding healthcare infrastructure and surgical capabilities, emerging markets also offer growth potential for hemostasis and tissue sealing agents. However, high costs and potential allergic reactions may restrain the growth of hemostasis and tissue sealing agents.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hemostasis and Tissue Sealing Agents. The growth and trends of Hemostasis and Tissue Sealing Agents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hemostasis and Tissue Sealing Agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Topical Hemostat (Active, Mechanical, Flowable)
  • Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products)

By Material

  • Gelatin-Based Topical Hemostats
  • Collagen-Based Topical Hemostats
  • ORC-based Topical Hemostats
  • Polysaccharide-Based Topical Hemostats

By Application

  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hemostasis and Tissue Sealing Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hemostasis and Tissue Sealing Agents market include Johnson & Johnson, CryoLife Inc., Advance Medical Solution (AMS) Group Plc., Cohera Medical Inc., Integra Life Sciences Corporation, Pfizer Inc., BD, Baxter, HyperBranch Medical Technology, Biomet Inc, B Braun Medical Inc, Smith & Nephew. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HEMOSTASIS AND TISSUE SEALING AGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Material
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Topical Hemostat (Active, Mechanical, Flowable) Historic and Forecast Sales By Regions
  • 5.4. Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Historic and Forecast Sales By Regions

6. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY MATERIAL

  • 6.1. Overview By Material
  • 6.2. Historical and Forecast Data Analysis By Material
  • 6.3. Gelatin-Based Topical Hemostats Historic and Forecast Sales By Regions
  • 6.4. Collagen-Based Topical Hemostats Historic and Forecast Sales By Regions
  • 6.5. ORC-based Topical Hemostats Historic and Forecast Sales By Regions
  • 6.6. Polysaccharide-Based Topical Hemostats Historic and Forecast Sales By Regions

7. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. General Surgery Historic and Forecast Sales By Regions
  • 7.4. Neurosurgery Historic and Forecast Sales By Regions
  • 7.5. Vascular Surgery Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Surgery Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HEMOSTASIS AND TISSUE SEALING AGENTS COMPANIES

  • 10.1. Hemostasis and Tissue Sealing Agents Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF HEMOSTASIS AND TISSUE SEALING AGENTS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Johnson & Johnson
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. CryoLife Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Advance Medical Solution (AMS) Group Plc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Cohera Medical Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Integra Life Sciences Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Pfizer Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. BD
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Baxter
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. HyperBranch Medical Technology
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Biomet Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. B Braun Medical Inc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Smith & Nephew
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Topical Hemostat (Active, Mechanical, Flowable) Market Sales By Geography (USD MN)
  • Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Market Sales By Geography (USD MN)
  • Analysis By Material (USD MN)
  • Gelatin-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Collagen-Based Topical Hemostats Market Sales By Geography (USD MN)
  • ORC-based Topical Hemostats Market Sales By Geography (USD MN)
  • Polysaccharide-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • General Surgery Market Sales By Geography (USD MN)
  • Neurosurgery Market Sales By Geography (USD MN)
  • Vascular Surgery Market Sales By Geography (USD MN)
  • Cardiovascular Surgery Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Hemostasis and Tissue Sealing Agents Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hemostasis and Tissue Sealing Agents Report
  • Market Research Process
  • Market Research Methodology
  • Global Hemostasis and Tissue Sealing Agents Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Material
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Topical Hemostat (Active, Mechanical, Flowable) Market Sales By Geography (USD MN)
  • Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Market Sales By Geography (USD MN)
  • Global Market Analysis By Material (USD MN)
  • Gelatin-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Collagen-Based Topical Hemostats Market Sales By Geography (USD MN)
  • ORC-based Topical Hemostats Market Sales By Geography (USD MN)
  • Polysaccharide-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • General Surgery Market Sales By Geography (USD MN)
  • Neurosurgery Market Sales By Geography (USD MN)
  • Vascular Surgery Market Sales By Geography (USD MN)
  • Cardiovascular Surgery Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.